Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 45 | 2023 | 8547 | 2.600 |
Why?
|
Copper | 22 | 2023 | 368 | 2.110 |
Why?
|
Amyloid beta-Protein Precursor | 18 | 2020 | 1110 | 1.300 |
Why?
|
Amyloid beta-Peptides | 22 | 2020 | 3832 | 1.140 |
Why?
|
Molecular Imaging | 3 | 2020 | 818 | 0.910 |
Why?
|
Oligonucleotide Array Sequence Analysis | 10 | 2013 | 3775 | 0.860 |
Why?
|
Metals | 7 | 2010 | 736 | 0.820 |
Why?
|
Gene Order | 2 | 2013 | 169 | 0.810 |
Why?
|
beta-Endorphin | 1 | 2020 | 43 | 0.750 |
Why?
|
Amyloidosis | 3 | 2020 | 817 | 0.720 |
Why?
|
Drug Discovery | 2 | 2018 | 1057 | 0.700 |
Why?
|
Cathepsin D | 1 | 2020 | 59 | 0.690 |
Why?
|
Aspartic Acid Endopeptidases | 2 | 2020 | 311 | 0.690 |
Why?
|
Protein Biosynthesis | 10 | 2020 | 2105 | 0.690 |
Why?
|
Hallucinogens | 1 | 2023 | 194 | 0.690 |
Why?
|
Tauopathies | 1 | 2023 | 317 | 0.660 |
Why?
|
Osteonectin | 1 | 2019 | 33 | 0.650 |
Why?
|
Neuroprotective Agents | 3 | 2018 | 961 | 0.640 |
Why?
|
Medicine, Chinese Traditional | 1 | 2018 | 73 | 0.600 |
Why?
|
Behavior | 1 | 2020 | 540 | 0.590 |
Why?
|
Amyloid Precursor Protein Secretases | 2 | 2020 | 620 | 0.580 |
Why?
|
Protein Multimerization | 2 | 2020 | 983 | 0.540 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2020 | 1347 | 0.540 |
Why?
|
Drugs, Chinese Herbal | 1 | 2018 | 151 | 0.540 |
Why?
|
Algorithms | 11 | 2013 | 13981 | 0.530 |
Why?
|
Chelating Agents | 10 | 2010 | 384 | 0.530 |
Why?
|
Apoptosis | 2 | 2023 | 9501 | 0.500 |
Why?
|
Zinc | 12 | 2004 | 689 | 0.500 |
Why?
|
Fluorescent Dyes | 2 | 2020 | 1913 | 0.500 |
Why?
|
Iron | 13 | 2023 | 1786 | 0.480 |
Why?
|
Extracellular Matrix Proteins | 1 | 2019 | 829 | 0.470 |
Why?
|
Calcium-Binding Proteins | 1 | 2019 | 1067 | 0.460 |
Why?
|
Social Stigma | 1 | 2020 | 734 | 0.440 |
Why?
|
Stress, Physiological | 1 | 2020 | 1398 | 0.430 |
Why?
|
Protein Kinases | 1 | 2020 | 1612 | 0.430 |
Why?
|
Behavior, Animal | 1 | 2020 | 1866 | 0.420 |
Why?
|
Reactive Oxygen Species | 2 | 2020 | 2138 | 0.420 |
Why?
|
5' Untranslated Regions | 8 | 2018 | 256 | 0.400 |
Why?
|
Bursitis | 1 | 2012 | 80 | 0.400 |
Why?
|
Memantine | 1 | 2012 | 105 | 0.390 |
Why?
|
Cell Line, Tumor | 10 | 2020 | 16939 | 0.380 |
Why?
|
Dementia, Vascular | 1 | 2012 | 123 | 0.380 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 1741 | 0.370 |
Why?
|
Hydrogen Peroxide | 7 | 2004 | 732 | 0.360 |
Why?
|
Gene Expression | 3 | 2020 | 7588 | 0.360 |
Why?
|
Cost of Illness | 1 | 2020 | 1940 | 0.340 |
Why?
|
Energy Metabolism | 1 | 2020 | 2869 | 0.340 |
Why?
|
Pattern Recognition, Automated | 4 | 2012 | 994 | 0.330 |
Why?
|
Principal Component Analysis | 2 | 2011 | 940 | 0.330 |
Why?
|
Nanoparticles | 2 | 2020 | 1943 | 0.310 |
Why?
|
Oxidative Stress | 8 | 2023 | 3106 | 0.310 |
Why?
|
Computational Biology | 3 | 2010 | 3505 | 0.280 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2012 | 893 | 0.280 |
Why?
|
Brain Injuries | 1 | 2019 | 2044 | 0.280 |
Why?
|
Amyloid Neuropathies | 1 | 2006 | 15 | 0.270 |
Why?
|
Cobalt | 1 | 2006 | 155 | 0.270 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2008 | 161 | 0.270 |
Why?
|
Cushing Syndrome | 1 | 2008 | 241 | 0.260 |
Why?
|
Protein Structure, Secondary | 2 | 2008 | 1229 | 0.250 |
Why?
|
Brain | 14 | 2020 | 26951 | 0.240 |
Why?
|
Cluster Analysis | 5 | 2013 | 2698 | 0.240 |
Why?
|
Artificial Intelligence | 6 | 2011 | 2557 | 0.230 |
Why?
|
Gene Expression Profiling | 5 | 2012 | 9411 | 0.230 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5643 | 0.230 |
Why?
|
Trace Elements | 3 | 2020 | 196 | 0.220 |
Why?
|
Lysergic Acid Diethylamide | 1 | 2023 | 47 | 0.220 |
Why?
|
Peptide Fragments | 10 | 2006 | 5125 | 0.220 |
Why?
|
Genetic Diseases, Inborn | 1 | 2008 | 601 | 0.210 |
Why?
|
DNA Methylation | 3 | 2018 | 4373 | 0.210 |
Why?
|
Inflammation | 3 | 2023 | 10756 | 0.200 |
Why?
|
Iron Regulatory Protein 1 | 2 | 2013 | 37 | 0.200 |
Why?
|
Polymers | 2 | 2006 | 1621 | 0.200 |
Why?
|
Phthalic Acids | 1 | 2006 | 476 | 0.190 |
Why?
|
Parkinson Disease | 3 | 2012 | 2859 | 0.190 |
Why?
|
Humans | 65 | 2023 | 760621 | 0.190 |
Why?
|
Protein Structure, Tertiary | 1 | 2008 | 3800 | 0.180 |
Why?
|
alpha-Synuclein | 4 | 2013 | 749 | 0.180 |
Why?
|
Animals | 37 | 2023 | 167963 | 0.180 |
Why?
|
Cathepsin B | 1 | 2020 | 80 | 0.180 |
Why?
|
Inhibitory Concentration 50 | 1 | 2020 | 465 | 0.170 |
Why?
|
Apoferritins | 1 | 2018 | 16 | 0.160 |
Why?
|
Manganese Poisoning | 1 | 2018 | 13 | 0.160 |
Why?
|
Environmental Exposure | 3 | 2020 | 4412 | 0.160 |
Why?
|
Serotonin | 1 | 2023 | 1040 | 0.160 |
Why?
|
Genomics | 2 | 2020 | 5794 | 0.150 |
Why?
|
Flavanones | 1 | 2018 | 74 | 0.150 |
Why?
|
Mice, Transgenic | 7 | 2020 | 9530 | 0.150 |
Why?
|
Spectrum Analysis | 1 | 2020 | 453 | 0.150 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2020 | 461 | 0.150 |
Why?
|
Inflammasomes | 1 | 2023 | 530 | 0.150 |
Why?
|
Metals, Heavy | 1 | 1999 | 150 | 0.150 |
Why?
|
Neoplasms | 3 | 2020 | 22072 | 0.150 |
Why?
|
Nootropic Agents | 1 | 2018 | 157 | 0.140 |
Why?
|
Oxidation-Reduction | 9 | 2004 | 2222 | 0.140 |
Why?
|
Protein Binding | 8 | 2020 | 9335 | 0.140 |
Why?
|
S-Adenosylmethionine | 1 | 2018 | 213 | 0.130 |
Why?
|
Neurotoxicity Syndromes | 1 | 2020 | 299 | 0.130 |
Why?
|
Staining and Labeling | 1 | 2020 | 1089 | 0.130 |
Why?
|
Neurodegenerative Diseases | 2 | 2018 | 1084 | 0.120 |
Why?
|
Early Diagnosis | 1 | 2020 | 1180 | 0.120 |
Why?
|
Models, Genetic | 3 | 2011 | 3442 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 2 | 2012 | 36290 | 0.120 |
Why?
|
Amino Acid Sequence | 4 | 2020 | 13451 | 0.120 |
Why?
|
Myelin Sheath | 1 | 2018 | 652 | 0.110 |
Why?
|
Computer Simulation | 3 | 2020 | 6218 | 0.110 |
Why?
|
Mice | 17 | 2023 | 81208 | 0.110 |
Why?
|
Drugs, Investigational | 2 | 2006 | 214 | 0.110 |
Why?
|
Rats | 8 | 2020 | 23711 | 0.110 |
Why?
|
Metalloproteins | 2 | 2004 | 101 | 0.110 |
Why?
|
Models, Animal | 1 | 2020 | 2117 | 0.110 |
Why?
|
Myeloid Cells | 1 | 2018 | 820 | 0.110 |
Why?
|
Ferric Compounds | 2 | 2009 | 377 | 0.110 |
Why?
|
Joint Capsule | 1 | 2012 | 68 | 0.100 |
Why?
|
Databases, Genetic | 2 | 2009 | 1738 | 0.100 |
Why?
|
Ligands | 1 | 2018 | 3276 | 0.100 |
Why?
|
Membrane Proteins | 2 | 2008 | 7850 | 0.100 |
Why?
|
Dicloxacillin | 1 | 2011 | 9 | 0.100 |
Why?
|
Strophanthidin | 1 | 2011 | 15 | 0.100 |
Why?
|
Cardenolides | 1 | 2011 | 17 | 0.100 |
Why?
|
RNA, Messenger | 7 | 2013 | 12766 | 0.090 |
Why?
|
Synovitis | 1 | 2012 | 215 | 0.090 |
Why?
|
Pilot Projects | 4 | 2020 | 8555 | 0.090 |
Why?
|
Vanadium | 1 | 2010 | 54 | 0.090 |
Why?
|
Aluminum | 1 | 2010 | 152 | 0.090 |
Why?
|
Ligaments, Articular | 1 | 2012 | 300 | 0.090 |
Why?
|
Bayes Theorem | 1 | 2018 | 2326 | 0.080 |
Why?
|
Flow Cytometry | 1 | 2020 | 5870 | 0.080 |
Why?
|
Rotator Cuff | 1 | 2012 | 342 | 0.080 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 2 | 2010 | 511 | 0.080 |
Why?
|
Erythromycin | 2 | 2006 | 117 | 0.080 |
Why?
|
Ferritins | 2 | 2008 | 597 | 0.080 |
Why?
|
Magnesium | 2 | 2010 | 810 | 0.080 |
Why?
|
Clioquinol | 3 | 2006 | 23 | 0.080 |
Why?
|
Nucleic Acid Conformation | 2 | 2010 | 899 | 0.080 |
Why?
|
Paroxetine | 2 | 2006 | 182 | 0.080 |
Why?
|
Neurofibrillary Tangles | 1 | 2011 | 457 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2008 | 15789 | 0.080 |
Why?
|
Least-Squares Analysis | 1 | 2008 | 369 | 0.080 |
Why?
|
Acetylcysteine | 2 | 2006 | 264 | 0.070 |
Why?
|
Manganese | 1 | 2010 | 395 | 0.070 |
Why?
|
Iron Chelating Agents | 2 | 2006 | 138 | 0.070 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 508 | 0.070 |
Why?
|
Software Design | 1 | 2007 | 171 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2852 | 0.070 |
Why?
|
Models, Chemical | 2 | 2006 | 614 | 0.070 |
Why?
|
Cerebral Cortex | 3 | 2018 | 5761 | 0.070 |
Why?
|
Response Elements | 2 | 2013 | 308 | 0.070 |
Why?
|
Collagen Type I | 1 | 2010 | 616 | 0.070 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2010 | 507 | 0.070 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2008 | 283 | 0.070 |
Why?
|
Quality Control | 1 | 2009 | 828 | 0.070 |
Why?
|
Hair | 1 | 2010 | 497 | 0.070 |
Why?
|
Intracellular Fluid | 1 | 2006 | 201 | 0.070 |
Why?
|
Neurons | 8 | 2013 | 9426 | 0.070 |
Why?
|
Untranslated Regions | 1 | 2006 | 29 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14660 | 0.070 |
Why?
|
Iron-Regulatory Proteins | 1 | 2006 | 30 | 0.070 |
Why?
|
Second Messenger Systems | 1 | 2006 | 202 | 0.070 |
Why?
|
Ovarian Neoplasms | 2 | 2013 | 4878 | 0.060 |
Why?
|
Shoulder Joint | 1 | 2012 | 732 | 0.060 |
Why?
|
Immunohistochemistry | 4 | 2010 | 11071 | 0.060 |
Why?
|
Porosity | 1 | 2006 | 349 | 0.060 |
Why?
|
Drug Design | 1 | 2010 | 1061 | 0.060 |
Why?
|
Molecular Sequence Data | 6 | 2013 | 17624 | 0.060 |
Why?
|
User-Computer Interface | 1 | 2012 | 1403 | 0.060 |
Why?
|
Aged | 9 | 2019 | 169152 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2013 | 22053 | 0.060 |
Why?
|
Tyrosine | 3 | 2004 | 1438 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2018 | 11903 | 0.060 |
Why?
|
Cyclophosphamide | 1 | 2010 | 2221 | 0.060 |
Why?
|
In Situ Hybridization | 1 | 2008 | 1900 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2020 | 18137 | 0.060 |
Why?
|
Depression | 1 | 2023 | 8044 | 0.060 |
Why?
|
Dementia | 1 | 2018 | 2649 | 0.060 |
Why?
|
Lens, Crystalline | 2 | 2003 | 388 | 0.060 |
Why?
|
Electron Spin Resonance Spectroscopy | 2 | 2001 | 162 | 0.050 |
Why?
|
Female | 12 | 2020 | 391270 | 0.050 |
Why?
|
Cytokines | 1 | 2018 | 7343 | 0.050 |
Why?
|
Signal Transduction | 3 | 2018 | 23376 | 0.050 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 318 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2019 | 58995 | 0.050 |
Why?
|
Sirolimus | 1 | 2010 | 1547 | 0.050 |
Why?
|
Aqueous Humor | 1 | 2003 | 153 | 0.050 |
Why?
|
Cells, Cultured | 8 | 2013 | 18957 | 0.050 |
Why?
|
Cell Survival | 5 | 2018 | 5797 | 0.050 |
Why?
|
Heat-Shock Response | 1 | 2023 | 179 | 0.050 |
Why?
|
China | 1 | 2008 | 2339 | 0.050 |
Why?
|
Crystallography, X-Ray | 1 | 2006 | 1982 | 0.050 |
Why?
|
Superoxides | 2 | 2000 | 387 | 0.050 |
Why?
|
Middle Aged | 7 | 2019 | 220352 | 0.050 |
Why?
|
Brain Chemistry | 1 | 2004 | 959 | 0.050 |
Why?
|
3-Hydroxyanthranilic Acid | 1 | 2000 | 8 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2825 | 0.050 |
Why?
|
Antioxidants | 2 | 2010 | 1667 | 0.050 |
Why?
|
Crystallins | 1 | 2000 | 75 | 0.040 |
Why?
|
Drug Approval | 2 | 2005 | 816 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4573 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 2006 | 1993 | 0.040 |
Why?
|
Microscopy, Fluorescence | 1 | 2007 | 2651 | 0.040 |
Why?
|
Neurotoxins | 1 | 2001 | 240 | 0.040 |
Why?
|
Neuroblastoma | 2 | 2006 | 1252 | 0.040 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 1999 | 45 | 0.040 |
Why?
|
Kynurenine | 1 | 2000 | 139 | 0.040 |
Why?
|
Prions | 1 | 2001 | 179 | 0.040 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2010 | 1463 | 0.040 |
Why?
|
Ferrous Compounds | 1 | 1999 | 41 | 0.040 |
Why?
|
Protein Modification, Translational | 1 | 2018 | 21 | 0.040 |
Why?
|
Isoenzymes | 1 | 2004 | 1690 | 0.040 |
Why?
|
Amyloid | 1 | 2004 | 842 | 0.040 |
Why?
|
Cell Nucleus | 1 | 2007 | 2907 | 0.040 |
Why?
|
Blotting, Western | 3 | 2013 | 5039 | 0.040 |
Why?
|
Mental Disorders | 1 | 2018 | 6796 | 0.040 |
Why?
|
Homocysteine | 1 | 2001 | 640 | 0.040 |
Why?
|
Age Factors | 2 | 2013 | 18416 | 0.040 |
Why?
|
Chromatography, Gel | 1 | 1997 | 645 | 0.040 |
Why?
|
Image Enhancement | 1 | 2007 | 2881 | 0.030 |
Why?
|
Macromolecular Substances | 1 | 1999 | 1433 | 0.030 |
Why?
|
Adult | 4 | 2019 | 219994 | 0.030 |
Why?
|
Apolipoproteins E | 2 | 1999 | 1436 | 0.030 |
Why?
|
Acidosis | 1 | 1998 | 268 | 0.030 |
Why?
|
Calcium | 2 | 2006 | 5725 | 0.030 |
Why?
|
Dopamine | 1 | 2002 | 1595 | 0.030 |
Why?
|
Databases, Factual | 1 | 2011 | 8035 | 0.030 |
Why?
|
Synapses | 1 | 2004 | 1757 | 0.030 |
Why?
|
Methylation | 1 | 2018 | 1082 | 0.030 |
Why?
|
Species Specificity | 1 | 1999 | 2418 | 0.030 |
Why?
|
Models, Statistical | 1 | 2009 | 5075 | 0.030 |
Why?
|
Male | 6 | 2019 | 359744 | 0.030 |
Why?
|
Homeostasis | 2 | 2008 | 3306 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2002 | 1091 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 2004 | 1544 | 0.030 |
Why?
|
Deferoxamine | 2 | 2006 | 153 | 0.030 |
Why?
|
Physostigmine | 1 | 2013 | 50 | 0.030 |
Why?
|
Base Sequence | 3 | 2013 | 12446 | 0.030 |
Why?
|
Cholesterol | 1 | 2002 | 2924 | 0.030 |
Why?
|
Logistic Models | 1 | 2008 | 13314 | 0.030 |
Why?
|
Plaque, Amyloid | 2 | 2010 | 758 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2013 | 1055 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2011 | 7408 | 0.030 |
Why?
|
Oxygen | 2 | 2000 | 4193 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 2009 | 5130 | 0.020 |
Why?
|
Feces | 1 | 2018 | 1455 | 0.020 |
Why?
|
Molecular Probe Techniques | 1 | 2012 | 117 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2010 | 2502 | 0.020 |
Why?
|
Protease Nexins | 1 | 2010 | 39 | 0.020 |
Why?
|
Cross-Linking Reagents | 2 | 2004 | 685 | 0.020 |
Why?
|
Chelation Therapy | 1 | 2010 | 77 | 0.020 |
Why?
|
Histidine | 2 | 2001 | 311 | 0.020 |
Why?
|
Protein Conformation | 1 | 1997 | 3969 | 0.020 |
Why?
|
Databases, Protein | 1 | 2012 | 388 | 0.020 |
Why?
|
Catalysis | 2 | 2002 | 775 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 25942 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2010 | 428 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 11712 | 0.020 |
Why?
|
Models, Molecular | 2 | 2012 | 5434 | 0.020 |
Why?
|
Free Radicals | 2 | 1999 | 238 | 0.020 |
Why?
|
Lewy Bodies | 1 | 2009 | 144 | 0.020 |
Why?
|
Mice, Inbred Strains | 2 | 2001 | 1763 | 0.020 |
Why?
|
Levodopa | 1 | 2009 | 217 | 0.020 |
Why?
|
Macrophages | 1 | 2023 | 5745 | 0.020 |
Why?
|
Cell Line | 2 | 2018 | 15620 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2013 | 858 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2010 | 17790 | 0.020 |
Why?
|
Aniline Compounds | 1 | 2013 | 1069 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2009 | 370 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 8158 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2010 | 658 | 0.020 |
Why?
|
Receptors, Transferrin | 1 | 2008 | 291 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2006 | 10827 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 2 | 2009 | 1974 | 0.020 |
Why?
|
Brain Neoplasms | 2 | 2007 | 8986 | 0.020 |
Why?
|
Normal Distribution | 1 | 2007 | 273 | 0.020 |
Why?
|
Cell Compartmentation | 1 | 2007 | 384 | 0.020 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2006 | 189 | 0.020 |
Why?
|
Transfection | 2 | 2006 | 5781 | 0.020 |
Why?
|
Type C Phospholipases | 1 | 2006 | 287 | 0.020 |
Why?
|
Cataract | 2 | 2003 | 827 | 0.020 |
Why?
|
Time Factors | 2 | 2004 | 40165 | 0.020 |
Why?
|
Down Syndrome | 1 | 2013 | 892 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 22023 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 2002 | 6131 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3758 | 0.010 |
Why?
|
Synaptic Transmission | 1 | 2010 | 1171 | 0.010 |
Why?
|
Young Adult | 1 | 2011 | 58741 | 0.010 |
Why?
|
ROC Curve | 1 | 2011 | 3568 | 0.010 |
Why?
|
Tumor Burden | 1 | 2010 | 1895 | 0.010 |
Why?
|
Sodium Dodecyl Sulfate | 1 | 2004 | 127 | 0.010 |
Why?
|
Feedback | 1 | 2007 | 791 | 0.010 |
Why?
|
Macaca mulatta | 1 | 2010 | 2316 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3607 | 0.010 |
Why?
|
Genetic Loci | 1 | 2013 | 2618 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2004 | 814 | 0.010 |
Why?
|
Kinetics | 2 | 2001 | 6377 | 0.010 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2004 | 267 | 0.010 |
Why?
|
Adolescent | 1 | 2011 | 87810 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2009 | 21025 | 0.010 |
Why?
|
Dimerization | 1 | 2004 | 891 | 0.010 |
Why?
|
Binding Sites | 2 | 2001 | 6048 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2006 | 1199 | 0.010 |
Why?
|
Resins, Synthetic | 1 | 2001 | 25 | 0.010 |
Why?
|
Cation Exchange Resins | 1 | 2001 | 19 | 0.010 |
Why?
|
Nephelometry and Turbidimetry | 1 | 2001 | 92 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2004 | 687 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2010 | 3584 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2009 | 2210 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2004 | 599 | 0.010 |
Why?
|
Synaptophysin | 1 | 2001 | 139 | 0.010 |
Why?
|
Ultracentrifugation | 1 | 2001 | 183 | 0.010 |
Why?
|
Circular Dichroism | 1 | 2001 | 348 | 0.010 |
Why?
|
Risk Factors | 2 | 2006 | 74359 | 0.010 |
Why?
|
Endoplasmic Reticulum | 1 | 2006 | 1132 | 0.010 |
Why?
|
Luciferases | 1 | 2002 | 716 | 0.010 |
Why?
|
Immunoblotting | 1 | 2004 | 1649 | 0.010 |
Why?
|
Cognition | 1 | 2018 | 6957 | 0.010 |
Why?
|
Guanosine | 1 | 2000 | 49 | 0.010 |
Why?
|
Electrochemistry | 1 | 2000 | 143 | 0.010 |
Why?
|
Cell-Free System | 1 | 2000 | 341 | 0.010 |
Why?
|
Phenanthrolines | 1 | 1999 | 51 | 0.010 |
Why?
|
Ethylenediamines | 1 | 1999 | 57 | 0.010 |
Why?
|
Egtazic Acid | 1 | 1999 | 169 | 0.010 |
Why?
|
Ions | 1 | 2000 | 261 | 0.010 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2001 | 550 | 0.010 |
Why?
|
Chemical Precipitation | 1 | 1999 | 176 | 0.010 |
Why?
|
Centrifugation | 1 | 1999 | 122 | 0.010 |
Why?
|
RNA | 1 | 2009 | 2722 | 0.010 |
Why?
|
Methionine | 1 | 2001 | 569 | 0.010 |
Why?
|
Apolipoprotein E3 | 1 | 1999 | 107 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2002 | 1249 | 0.010 |
Why?
|
Apolipoprotein E2 | 1 | 1999 | 135 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2002 | 1529 | 0.010 |
Why?
|
Filtration | 1 | 1999 | 229 | 0.010 |
Why?
|
Iohexol | 1 | 1999 | 204 | 0.010 |
Why?
|
Tryptophan | 1 | 2000 | 479 | 0.010 |
Why?
|
Data Collection | 1 | 2007 | 3315 | 0.010 |
Why?
|
tau Proteins | 1 | 2008 | 2085 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2001 | 1693 | 0.010 |
Why?
|
Solubility | 1 | 1999 | 1088 | 0.010 |
Why?
|
Serum Albumin | 1 | 2000 | 674 | 0.010 |
Why?
|
Glutamine | 1 | 2000 | 576 | 0.010 |
Why?
|
Ascorbic Acid | 1 | 2000 | 655 | 0.010 |
Why?
|
Drug Synergism | 1 | 2001 | 1754 | 0.010 |
Why?
|
Arginine | 1 | 2000 | 934 | 0.010 |
Why?
|
Reference Values | 1 | 2003 | 4925 | 0.010 |
Why?
|
Enhancer Elements, Genetic | 1 | 2002 | 1356 | 0.010 |
Why?
|
Proteomics | 1 | 2009 | 3817 | 0.010 |
Why?
|
Dogs | 1 | 2000 | 3841 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6465 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2000 | 1167 | 0.010 |
Why?
|
Apolipoprotein E4 | 1 | 1999 | 707 | 0.010 |
Why?
|
Cattle | 1 | 2000 | 3847 | 0.010 |
Why?
|
Protein Isoforms | 1 | 1999 | 1697 | 0.010 |
Why?
|
Amino Acids | 1 | 2000 | 1714 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2001 | 2192 | 0.010 |
Why?
|
Cerebellum | 1 | 2001 | 1496 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2009 | 8515 | 0.010 |
Why?
|
Water | 1 | 1999 | 1407 | 0.010 |
Why?
|
Glioma | 1 | 2007 | 3420 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 3804 | 0.010 |
Why?
|
Peptides | 1 | 2004 | 4354 | 0.010 |
Why?
|
Regression Analysis | 1 | 2000 | 6360 | 0.010 |
Why?
|
Glioblastoma | 1 | 2006 | 3484 | 0.010 |
Why?
|
Models, Biological | 1 | 2006 | 9467 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2001 | 14372 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2010 | 13262 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2009 | 65017 | 0.000 |
Why?
|
Aging | 1 | 1999 | 8651 | 0.000 |
Why?
|
United States | 1 | 2002 | 72461 | 0.000 |
Why?
|